{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T16:34:14Z","timestamp":1776875654067,"version":"3.51.2"},"reference-count":24,"publisher":"Bentham Science Publishers Ltd.","issue":"3","funder":[{"DOI":"10.13039\/501100004697","name":"Hamadan University of Medical Sciences","doi-asserted-by":"publisher","award":["9510146103"],"award-info":[{"award-number":["9510146103"]}],"id":[{"id":"10.13039\/501100004697","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PNT"],"published-print":{"date-parts":[[2020,9,30]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Insulin, like most peptides, is classified as a hydrophilic and macromolecular\ndrug that is considered as a low permeable and unstable compound in the gastrointestinal (GI) tract.\nThe acidic condition of the stomach can degrade insulin molecules. Moreover, the presence of proteolytic\nactivities of some enzymes such as trypsin and chymotrypsin can hydrolyze amide-bonds between\nvarious amino-acids in the structures of peptides and proteins. However, due to its simplicity\nand high patient compliance, oral administration is the most preferred route of systemic drug delivery,\nand for the development of an oral delivery system, some obstacles in oral administration of peptides\nand proteins including low permeability and low stability of the proteins in GI should be overcome.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p> In this study, the effects of orally insulin nanoparticles (INPs) prepared from quaternerized\nN-aryl derivatives of chitosan on the biochemical factors of the liver in diabetic rats were studied.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>INPs composed of methylated (amino benzyl) chitosan were prepared by the PEC method.\nLyophilized INPs were filled in pre-clinical capsules, and the capsules were enteric-coated with Eudragit\nL100. Twenty Male Wistar rats were randomly divided into four groups: group1: normal control\nrats, group 2: diabetic rats, group 3: diabetic rats received capsules INPs(30 U\/kg\/day, orally), group 4:\nthe diabetic rats received regular insulin (5 U\/kg\/day, subcutaneously). At the end of the treatment, serum,\nliver and kidney tissues were collected. Biochemical parameters in serum were measured using\nspectrophotometric methods. Also, oxidative stress was measured in plasma, liver and kidney. Histological\nstudies were performed using H and E staining .<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Biochemical parameters, and liver and kidney injury markers in serum of the diabetic rats that\nreceived INPs improved significantly compared with the diabetic group. INPs reduced oxidative toxic\nstress biomarkers in serum, liver and kidney of the diabetic treated group. Furthermore, a histopathological\nchange was developed in the treated groups.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Capsulated INPs can prevent diabetic liver and oxidative kidney damages (similar regular\ninsulin). Therefore oral administration of INPs appears to be safe.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Lay Summary:<\/jats:title>\n<jats:p> Although oral route is the most preferred route of administration, but oral delivery of\npeptides and proteins is still a challenging issue. Diabetes Mellitus may lead to severe complications,\nwhich most of them are life-threatening. In this study, we are testing the toxicity of oral insulin nanoparticles\nin kidney and liver of rats. For this investigation, we will prepare insulin nanoparticles\ncomposed of a quaternized derivative of chitosan. The nanoparticles will be administered orally to\nrats and the level of oxidative stress in their liver and kidney will be determined. The data will be\ncompared to the subcutaneous injection of insulin.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/2211738508666200628033442","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T06:18:28Z","timestamp":1593497908000},"page":"239-254","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Eudragit L-100 Capsules Aromatize and Quaternerize Chitosan for Insulin Nanoparticle Oral Delivery During Toxic Oxidative Stress in Rat Liver and Kidney"],"prefix":"10.2174","volume":"8","author":[{"given":"Reza","family":"Mahjub","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzane K.","family":"Najafabadi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, School of Pharmacy, Medicinal Plants and Natural Products Research Center, Hamadan University of Medical Sciences, Hamadan, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narges","family":"Dehkhodaei","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, School of Pharmacy, Medicinal Plants and Natural Products Research Center, Hamadan University of Medical Sciences, Hamadan, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nejat","family":"Kheiripour","sequence":"additional","affiliation":[{"name":"Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir N.","family":"Ahmadabadi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara S.","family":"Asl","sequence":"additional","affiliation":[{"name":"Anatomy Department, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masomeh","family":"Taheri-Azandariani","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, School of Pharmacy, Medicinal Plants and Natural Products Research Center, Hamadan University of Medical Sciences, Hamadan, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akram","family":"Ranjbar","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, School of Pharmacy, Medicinal Plants and Natural Products Research Center, Hamadan University of Medical Sciences, Hamadan, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jep.2007.10.038","volume":"115","author":"Fr\u00f6de T.S.","year":"2008","unstructured":"Fr\u00f6de T.S.; Medeiros Y.S.; Animal models to test drugs with potential antidiabetic activity. J Ethnopharmacol 2008,115(2),173-183","journal-title":"J Ethnopharmacol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1177\/193229681300700228","volume":"7","author":"Fonte P.","year":"2013","unstructured":"Fonte P.; Ara\u00fajo F.; Reis S.; Sarmento B.; Oral insulin delivery: how far are we? J Diabetes Sci Technol 2013,7(2),520-531","journal-title":"J Diabetes Sci Technol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.3109\/03639045.2013.841187","volume":"40","author":"Mahjub R.","year":"2014","unstructured":"Mahjub R.; Radmehr M.; Dorkoosh F.A.; Ostad S.N.; Rafiee-Tehrani M.; Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations. Drug Dev Ind Pharm 2014,40(12),1645-1659","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1208\/s12249-019-1325-z","volume":"20","author":"Cao S.J.","year":"2019","unstructured":"Cao S.J.; Xu S.; Wang H.M.; Nanoparticles: oral delivery for protein and peptide drugs. AAPS PharmSciTech 2019,20(5),190","journal-title":"AAPS PharmSciTech"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jconrel.2005.12.015","volume":"111","author":"Prego C.","year":"2006","unstructured":"Prego C.; Torres D.; Fernandez-Megia E.; Novoa-Carballal R.; Qui\u00f1o\u00e1 E.; Alonso M.J.; Chitosan-PEG nanocapsules as new carriers for oral peptide delivery. Effect of chitosan pegylation degree. J Control Release 2006,111(3),299-308","journal-title":"J Control Release"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.lfs.2019.02.016","volume":"221","author":"Shateri H.","year":"2019","unstructured":"Shateri H.; Ranjbar A.; Kheiripour N.; Tempol improves oxidant\/antioxidant parameters in testicular tissues of diabetic rats. Life Sci 2019,221,65-71","journal-title":"Life Sci"},{"key":"ref=7","first-page":"84","volume":"12","author":"Ranjbar A.","year":"2018","unstructured":"Ranjbar A.; Kheiripour N.; Ghasemi H.; Seif Rabiei M.A.; Dadras F.; Khoshjou F.; Antioxidative effects of tempol on mitochondrial dysfunction in diabetic nephropathy. Iran J Kidney Dis 2018,12(2),84-90","journal-title":"Iran J Kidney Dis"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.biopha.2017.10.097","volume":"97","author":"Jamshidi M.","year":"2018","unstructured":"Jamshidi M.; Ziamajidi N.; Khodadadi I.; Dehghan A.; Kalantarian G.; Abbasalipourkabir R.; The effect of insulin-loaded trimethylchitosan nanoparticles on rats with diabetes type I. Biomed Pharmacother 2018,97,729-735","journal-title":"Biomed Pharmacother"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1208\/s12249-011-9716-9","volume":"12","author":"Mahjub R.","year":"2011","unstructured":"Mahjub R.; Dorkoosh F.A.; Amini M.; Khoshayand M.R.; Rafiee-Tehrani M.; Preparation, statistical optimization, and in vitro characterization of insulin nanoparticles composed of quaternized aromatic derivatives of chitosan. AAPS PharmSciTech 2011,12(4),1407-1419","journal-title":"AAPS PharmSciTech"},{"key":"ref=10","first-page":"810","volume":"23","author":"Keiripour N.","year":"2020","unstructured":"Keiripour N.; The effects of synthetic orally administrated insulin nanoparticles in comparison to injectable insulin on the renal function markers of type 1-diabetic rats. Iran J Basic Med Sci 2020,23(6),810-818","journal-title":"Iran J Basic Med Sci"},{"key":"ref=11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2013.08.270","volume":"172","author":"Mahjub R.","year":"2013","unstructured":"Mahjub R.; Dorkoosh F.A.; Amini M.; In vitro characterization and cell cytotoxicity of insulin nanoparticles composed of quaternized aromatic derivatives of chitosan. J Control Release 2013,172(1)","journal-title":"J Control Release"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.2147\/DDDT.S79885","volume":"9","author":"Qinna N.A.","year":"2015","unstructured":"Qinna N.A.; Badwan A.A.; Impact of streptozotocin on altering normal glucose homeostasis during insulin testing in diabetic rats compared to normoglycemic rats. Drug Des Devel Ther 2015,9,2515-2525","journal-title":"Drug Des Devel Ther"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0076-6879(99)99005-5","volume":"299","author":"Benzie I.F.","year":"1999","unstructured":"Benzie I.F.; Strain J.J.; Ferric reducing\/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol 1999,299,15-27","journal-title":"Methods Enzymol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S0076-6879(94)33044-1","volume":"233","author":"Hu M.L.","year":"1994","unstructured":"Hu M.L.; Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 1994,233,380-385","journal-title":"Methods Enzymol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1006\/abbi.1997.0352","volume":"347","author":"Gergel\u2019 D.","year":"1997","unstructured":"Gergel\u2019 D.; Cederbaum A.I.; Interaction of nitric oxide with 2-thio-5-nitrobenzoic acid: implications for the determination of free sulfhydryl groups by Ellman\u2019s reagent. Arch Biochem Biophys 1997,347(2),282-288","journal-title":"Arch Biochem Biophys"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1208\/s12249-016-0594-z","volume":"18","author":"Chen S.","year":"2017","unstructured":"Chen S.; Guo F.; Deng T.; Eudragit S100-Coated Chitosan Nanoparticles Co-loading Tat for Enhanced oral colon absorption of insulin. AAPS PharmSciTech 2017,18(4),1277-1287","journal-title":"AAPS PharmSciTech"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/10717540801905165","volume":"15","author":"Reis C.P.","year":"2008","unstructured":"Reis C.P.; Ribeiro A.J.; Veiga F.; Neufeld R.J.; Damg\u00e9 C.; Polyelectrolyte biomaterial interactions provide nanoparticulate carrier for oral insulin delivery. Drug Deliv 2008,15(2),127-139","journal-title":"Drug Deliv"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.msec.2016.05.010","volume":"67","author":"Sharma S.","year":"2016","unstructured":"Sharma S.; Jyoti K.; Sinha R.; Katyal A.; Jain U.K.; Madan J.; Protamine coated proliposomes of recombinant human insulin encased in Eudragit S100 coated capsule offered improved peptide delivery and permeation across Caco-2 cells. Mater Sci Eng C 2016,67,378-385","journal-title":"Mater Sci Eng C"},{"key":"ref=19","first-page":"19","volume":"26","author":"Wilcox G.","year":"2005","unstructured":"Wilcox G.; Insulin and insulin resistance. The Clinical biochemist. Reviews 2005,26(2),19-39","journal-title":"Reviews"},{"key":"ref=20","first-page":"1035","volume":"21","author":"Heidarisasan S.","year":"2018","unstructured":"Heidarisasan S.; Ziamajidi N.; Karimi J.; Abbasalipourkabir R.; Effects of insulin-loaded chitosan-alginate nanoparticles on RAGE expression and oxidative stress status in the kidney tissue of rats with type 1 diabetes. Iran J Basic Med Sci 2018,21(10),1035-1042","journal-title":"Iran J Basic Med Sci"},{"key":"ref=21","first-page":"1","volume":"2013","author":"Sahu S.K.","year":"2013","unstructured":"Sahu S.K.; Development and evaluation of insulin incorporated nanoparticles for oral administration. ISRN Nanotechnology 2013,2013,1-6","journal-title":"ISRN Nanotechnology"},{"key":"ref=22","first-page":"108","volume":"44","author":"Kheiripour N.","year":"2019","unstructured":"Kheiripour N.; Karimi J.; Khodadadi I.; Tavilani H.; Taghi Goodarzi M.; Hashemnia M.; Hepatoprotective effects of silymarin on liver injury via irisin upregulation and oxidative stress reduction in rats with type 2 diabetes. Iran J Med Sci 2019,44(2),108-117","journal-title":"Iran J Med Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.17221\/7495-CJAS","volume":"59","author":"Olya S.","year":"2014","unstructured":"Olya S.; Oral delivery of insulin-loaded nanoparticles in diabetic rabbits and in sheep. Czech J Anim Sci 2014,59,251-256","journal-title":"Czech J Anim Sci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ejpb.2016.11.037","volume":"113","author":"Lopes M.","year":"2017","unstructured":"Lopes M.; Aniceto D.; Abrantes M.; In vivo biodistribution of antihyperglycemic biopolymer-based nanoparticles for the treatment of type 1 and type 2 diabetes. Eur J Pharm Biopharm 2017,113,88-96","journal-title":"Eur J Pharm Biopharm"}],"container-title":["Pharmaceutical Nanotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/183229","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/183229\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/183229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T01:39:57Z","timestamp":1613525997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/183229\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,30]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9,30]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/2211738508666200628033442","relation":{},"ISSN":["2211-7385"],"issn-type":[{"value":"2211-7385","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,30]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-01-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}